RNAi based approaches to the treatment of malignant glioma

Technology in Cancer Research and Treatment

Volumn 5, Issue 3, 2006, Pages 261-269

  Mathupala, Saroj P ^a   Guthikonda, Murali ^a   Sloan, Andrew E ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; EPIDERMAL GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MICRORNA; PROTEIN KINASE C EPSILON; PROTEIN P53; RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

CANCER RESEARCH; CELL ADHESION; CELL INVASION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GLIOMA; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PROGNOSIS; REVIEW; RNA ANALYSIS; RNA INTERFERENCE; VALIDATION PROCESS;

EID: 33745393103     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460600500313     Document Type: Review

References (87)

1. Ignatova, T. N., Kukekov, V. G., Laywell, E. D., Suslov, O. N., Vrionis, F. D., and Steindler, D. A. Human Cortical Glial Tumors Contain Neural Stem-like Cells Expressing Astroglial and Neuronal Markers In Vitro. Glia 39, 193-206 (2002).
2. Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D. H., Bronner-Fraser, M., and Kornblum, H. I. Cancerous Stem Cells Can Arise From Pediatric Brain Tumors. Proc. Natl. Acad. Sci. USA 100, 15178-15183 (2003).
3. Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., and Dirks, P. B. Identification of a Cancer Stem Cell in Human Brain Tumors. Cancer Res. 63, 5821-5828 (2003).
4. Napoli, C., Lemieux, C., and Jorgensen, R. Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in Trans. Plant Cell 2, 279-289 (1990).
5. Guo, S. and Kemphues, K. J. par-1, A Gene Required for Establishing Polarity in C. elegans Embryos, Encodes a Putative Ser/Thr Kinase that is Asymmetrically Distributed. Cell 81, 611-620 (1995).
6. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. Potent and Specific Genetic Interference by Double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998).
7. Matzke, M. A. and Birchler, J. A. RNAi-mediated Pathways in the Nucleus. Nat. Rev. Genet. 6, 24-35 (2005).
8. Filipowicz, W. RNAi: The Nuts and Bolts of the RISC Machine. Cell 122, 17-20 (2005).
9. Dykxhoorn, D. M. and Lieberman, J. The Silent Revolution: RNA Interference as Basic Biology, Research Tool, and Therapeutic. Annu. Rev. Med. 56, 401-423 (2005).
10. Mittal, V. Improving the Efficiency of RNA Interference in Mammals. Nat. Rev. Genet. 5, 355-365 (2004).
11. Miyagishi, M. and Taira, K. U6 Promoter-driven siRNAs with Four Uridine 3′ Overhangs Efficiently Suppress Targeted Gene Expression in Mammalian Cells. Nat. Biotechnol. 20, 497-500 (2002).
12. Myslinski, E., Ame, J. C., Krol, A., and Carbon, P. An Unusually Compact External Promoter for RNA Polymerase III Transcription of the Human H1RNA Gene. Nucleic Acids Res. 29, 2502-2509 (2001).
13. Brummelkamp, T. R., Bernards, R., and Agami, R. A System For Stable Expression of Short Interfering RNAs in Mammalian Cells. Science 296, 550-553 (2002).
14. Khvorova, A., Reynolds, A., and Jayasena, S. D. Functional siRNAs and miRNAs Exhibit Strand Bias. Cell 115, 209-216 (2003).
15. Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., and Khvorova, A. Rational siRNA Design for RNA Interference. Nat. Biotechnol. 22, 326-330 (2004).
16. Schwarz, D. S., Hutvagner, G., Du, T, Xu, Z., Aronin, N., and Zamore, P. D. Asymmetry in the Assembly of the RNAi Enzyme Complex. Cell 115, 199-208 (2003).
17. Paddison, P. J., Caudy, A. A., and Hannon, G. J. Stable Suppression of Gene Expression by RNAi in Mammalian Cells. Proc. Natl. Acad. Sci. USA 99, 1443-1448 (2002).
18. Stewart, S. A., Dykxhoorn, D. M., Palliser, D., Mizuno, H., Yu, E. Y., An, D. S., Sabalini, D. M., Chen, I. S., Hahn, W. C., Sharp, P. A., Weinberg, R. A., and Novina, C. D. Lentivirus-delivered Stable Gene Silencing by RNAi in Primary Cells. RNA. 9, 493-501 (2003).
19. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., and Bujard, H. Transcriptional Activation by Tetracyclines in Mammalian Cells. Science 268, 1766-1769 (1995).
20. Gossen, M., Bonin, A. L., Freundlieb, S., and Bujard, H. Inducible Gene Expression Systems for Higher Eukaryotic Cells. Curr. Opin. Biotechnol. 5, 516-520 (1994).
21. Gossen, M. and Bujard, H. Tight Control of Gene Expression in Mammalian Cells by Tetracycline-responsive Promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551 (1992).
22. Szulc, J., Wiznerowicz, M., Sauvain, M. O., Trono, D., and Aebischer, P. A Versatile Tool for Conditional Gene Expression and Knockdown. Nat. Methods 3, 109-116 (2006).
23. Hosono, T., Mizuguchi, H., Katayama, K., Xu, Z. L., Sakurai, F., Ishii-Watabe, A., Kawabata, K., Yamaguchi, T., Nakagawa, S., Mayumi, T., and Hayakawa, T. Adenovirus Vector-mediated Doxycycline-inducible RNA Interference. Hum. Gene Ther. 15, 813-819 (2004).
24. Filipowicz, W., Jaskiewicz, L., Kolb, F. A., and Pillai, R. S. Post-transcriptional Gene Silencing by siRNAs and miRNAs. Curr. Opin. Struct. Biol. 15, 331-341 (2005).
25. Pillai, R. S. MicroRNA Function: Multiple Mechanisms for a Tiny RNA? RNA. 11, 1753-176 (2005).
26. Du, T. and Zumore, P. D. MicroPrimer: The Biogenesis and Function of MicroRNA. Development 132, 4645-4652 (2005).
27. Chi, J. T., Chang, H. Y. Wang, N. N., Chang, D. S., Dunphy, N., and Brown, P. O. Genomewide View of Gene Silencing by Small Interfering RNAs. Proc. Natl. Acad. Sci. USA 100, 6343-6346 (2003).
28. Semizarov, D., Frost, L., Sarthy, A., Kroeger, P., Halbert, D. N., and Fesik, S. W. Specificity of Short Interfering RNA Determined Through Gene Expression Signatures. Proc. Natl. Acad. Sci. USA 100, 6347-6352 (2003).
29. Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A. L., and Iggo, R. Induction of an Interferon Response by RNAi Vectors in Mammalian Cells. Nat. Genet. 34, 263-264 (2003).
30. Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., and Williams, B. R. Activation of the Interferon System by Short-interfering RNAs. Nat. Cell Biol. 5, 834-839 (2003).
31. Dillin, A. The Specifics of Small Interfering RNA Specificity. Proc. Natl. Acad. Sci. USA 100, 6289-6291 (2003).
32. Moss, E. G. and Taylor, J. M. Small-interfering RNAs in the Radar of the Interferon System. Nat. Cell Biol. 5, 771-772 (2003).
33. Persengiev, S. P., Zhu, X., and Green, M. R. Nonspecific. Concentration-dependent Stimulation and Repression of Mammalian Gene Expression by Small Interfering RNAs (siRNAs). RNA. 10, 12-18 (2004).
34. Moss, E. G. and Taylor, J. M. Small-interfering RNAs in the Radar of the Interferon System. Nat. Cell Biol. 5, 771-772 (2003).
35. Heidel, J. D., Hu, S., Liu, X. F., Triche, T. J., and Davis, M. E. Lack of Interferon Response in Animals to Naked siRNAs. Nat. Biotechnol. 22, 1579-1582 (2004).
36. Kim, D. H., Longo, M., Han, Y., Lundberg, P., Cantin, E., and Rossi, J. J. Interferon Induction by siRNAs and ssRNAs Synthesized by Phage Polymerase. Nat. Biotechnol. 22, 321-325 (2004).
37. Adams, A. RNAi Inches Toward the Clinic. The Scientist 18, 32-39 (2004).
38. Tuschl, T. Zamore, P. D., Lehmann, R., Bartel, D. P., and Sharp, P. A. Targeted mRNA Degradation by Double-stranded RNA In Vitro. Genes Dev. 13, 3191-3197 (1999).
39. Murai, T., Miyazaki, Y., Nishinakamura, H., Sugahara, K. N., Miyauchi, T., Sako, Y., Yanagida, T., and Miyasaka, M. Engagement of CD44 Promotes Rac Activation and CD44 Cleavage During Tumor Cell Migration. J. Biol. Chem., 279, 4541-4550 (2004).
40. Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., and Rao, J. S. RNAi-mediated Inhibition of Cathepsin B and uPAR Leads to Decreased Cell Invasion, Angiogenesis and Tumor Growth in Gliomas. Oncogene 23, 8486-8496 (2004).
41. Lakka, S. S., Gondi, C. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M., and Rao, J. S. Inhibition of Cathepsin B and MMP-9 Gene Expression in Glioblastoma Cell Line Via RNA Interference Reduces Tumor Cell Invasion, Tumor Growth and Angiogenesis. Oncogene 23, 4681-4689 (2004).
42. Lakka, S. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., Gujrati, M., Rao, V. H., Sioka, C., and Rao, J. S. Specific Interference of Urokinase-type Plasminogen Activator Receptor and Matrix Metalloproteinase-9 Gene Expression Induced by Double-stranded RNA Results in Decreased Invasion, Tumor Growth, and Angiogenesis in Gliomas. J. Biol. Chem. 280, 21882-21892 (2005).
43. Bornhauser, B. C. and Lindholm, D. MSAP Enhances Migration of C6 Glioma Cells Through Phosphorylation of the Myosin Regulatory Light Chain. Cell Mol. Life Sci. 62, 1260-1266 (2005).
44. Lipinski, C. A., Tran, N. L., Menashi, E., Rohl, C., Kloss, J., Bay, R. C., Berens, M. E., and Loftus, J. C. The Tyrosine Kinase pyk2 Promotes Migration and Invasion of Glioma Cells. Neoplasia, 7, 435-445 (2005).
45. Chan, A. Y., Coniglio, S. J., Chuang, Y. Y., Michaelson, D., Knaus, U. G., Philips, M. R., and Symons, M. Roles of the Rac1 and Rac3 GTPases in Human Tumor Cell Invasion. Oncogene 24, 7821-7829 (2005).
46. Zhang, J., Sarkar, S., and Yong, V. W. The Chemokine Stromal Cell Derived Factor-1 (CXCL12) Promotes Glioma Invasiveness Through MT2-matrix Metalloproteinase. Carcinogenesis 26, 2069-2077 (2005).
47. Nakada, M., Niska, J. A., Tran, N. L., McDonough, W. S., and Berens, M. E. EphB2/R-Ras Signaling Regulates Glioma Cell Adhesion, Growth, and Invasion. Am. J. Pathol. 167, 565-576 (2005).
48. Muller, S., Kunkel, P., Lamszus, K., Ulbricht, U., Lorente, G. A., Nelson, A. M., von Schack, D., Chin, D. J., Lohr, S. C., Westphal, M., and Melcher, T. A Role for Receptor Tyrosine Phosphatase Zeta in Glioma Cell Migration. Oncogene 22, 6661-6668 (2003).
49. Sloan, K. E., Eustace, B. K., Stewart, J. K., Zehetmeier, C., Torella, C., Simeone, M., Roy, J. E., Unger, C., Louis, D. N., Hag, L. L., and Jay, D. G. CD155/PVR Plays a Key Role in Cell Motility During Tumor Cell Invasion and Migration. BMC. Cancer 4, 73 (2004).
50. Ding, Y., Li, M., Zhang, J., Li, N., Xia, Z., Hu, Y., Wang, S., and Fan, G. H. The Heat Shock Cognate Protein 73 is a CXCR4 Binding Protein that Regulates the Receptor Endocytosis and the Receptor-mediated Chemotaxis. Mol. Pharmacol. (2005).
51. Sunayama, J., Ando, Y., Itoh, N., Tomiyama, A., Sakurada, K., Sugiyama, A., Kang, D., Tashiro, F., Gotoh, Y., Kuchino, Y., and Kitanaka, C. Physical and Functional Interaction Between BH3-only Protein Hrk and Mitochondrial Pore-forming Protein p32. Cell Death. Differ. 11, 771-781 (2004).
52. Hatano, M., Mizuno, M., and Yoshida, J. Enhancement of C2-ceramide Antitumor Activity by Small Interfering RNA on X Chromosome-linked Inhibitor of Apoptosis Protein in Resistant Human Glioma Cells. J. Neurosurg. 101, 119-127 (2004).
53. Tran, N. L., McDonough, W. S., Savitch, B. A., Sawyer, T. F., Winkles, J. A., and Berens, M. E. The Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK)-fibroblast Growth Factor-inducible 14 (Fn14) Signaling System Regulates Glioma Cell Survival Via NFkappaB Pathway Activation and BCL-XL/BCL-W Expression. J. Biol. Chem. 280, 3483-3492 (2005).
54. Okhrimenko, H., Lu, W., Xiang, C., Hamburger, N., Kazimirsky, G., and Brodie, C. Protein Kinase C-epsilon Regulates the Apoptosis and Survival of Glioma Cells. Cancer Res. 65, 7301-7309 (2005).
55. Konnikova, L., Kotecki, M., Kruger, M. M., and Cochran, B. H. Knockdown of STAT3 Expression by RNAi Induces Apoptosis in Astrocytoma Cells. BMC. Cancer 3, 23 (2003).
56. Kano, H., Arakawa, Y., Takahashi, J. A., Nozaki, K., Kawabata, Y., Takatsuka, K., Kageyama, R., Ueba, T., and Hashimoto, N. Overexpression of RFT Induces G1-S Arrest and Apoptosis Via p53/p21(Waf1) Pathway in Glioma Cell. Biochem. Biophys. Res. Commun. 317, 902-908 (2004).
57. Foehr, E. D., Lorente, G., Vincent, V., Nikolich, K., and Urfer, R. FAS Associated Phosphatase (FAP-1) Blocks Apoptosis of Astrocytomas Through Dephosphorylation of FAS. J. Neurooncol. 74, 241-248 (2005).
58. Kugler, W., Buchholz, F., Kohler, F., Eibl, H., Lakomek, M., and Erdlenbruch, B. Downregulation of Apaf-1 and Caspase-3 by RNA Interference in Human Glioma Cells: Consequences for Erucylphosphocholine-induced Apoptosis. Apoptosis. 10, 1163-1174 (2005).
59. Liu, X. H., Yu, E. Z., Li, Y. Y., Rollwagen, F. M., and Kagan, E. RNA Interference Targeting Akt Promotes Apoptosis in Hypoxia-exposed Human Neuroblastoma Cells. Brain Res. (2006).
60. Kang, C. S., Pu, P. Y. Wang, G. X., Li, Y. H., Dong, L., and Wang, H. Inhibitory Effects of siRNA Targeting Epidermal Growth Factor Receptor on Proliferation and Invasion of Human Glioblastoma Cells. Zhonghua Yi. Xue. Za Zhi. 84, 1503-1508 (2004).
61. Yamaguchi, K., Richardson, M. D., Bigner, D. D., and Kwatra, M. M. Signal Transduction Through Substance P Receptor in Human Glioblastoma Cells: Roles for Src and PKCdelta. Cancer Chemother. Pharmacol. 56, 585-593 (2005).
62. Saydam, O., Glauser, D. L., Heid, I., Turkeri, G., Hilbe, M., Jacobs, A. H., Ackermann, M., and Fraefel, C. Herpes Simplex Virus 1 Amplicon Vector-mediated siRNA Targeting Epidermal Growth Factor Receptor Inhibits Growth of Human Glioma Cells In Vivo. Mol. Ther. 12, 803-812 (2005).
63. Kang, C. S., Pu, P. Y., Li, Y. H., Zhang, Z. Y., Qiu, M. Z., Huang, Q., and Wang, G. X. An In Vitro Study on the Suppressive Effect of Glioma Cell Growth Induced by Plasmid-based Small Interference RNA (siRNA) Targeting Human Epidermal Growth Factor Receptor. J. Neurooncol. 74, 267-273 (2005).
64. Mathupala, S. P., Parajuli, P., and Sloan, A. E. Silencing of Monocarboxylate Transporters Via Small Interfering Ribonucleic Acid Inhibits Glycolysis and Induces Cell Death in Malignant Glioma: An In Vitro Study. Neurosurgery 55, 1410-1419 (2004).
65. Brown, R., Morash, B., Ur, E., and Wilkinson, M. RNAi-mediated Silencing of Leptin Gene Expression Increases Cell Death in C6 Glioblastoma Cells. Brain Res. Mol. Brain Res. 139, 357-360 (2005).
66. Hara, S., Nakashima, S., Kiyono, T., Sawada, M., Yoshimura, S., Iwama, T., Banno, Y., Shinoda, J., and Sakai, N. p53-Independent Ceramide Formation in Human Glioma Cells During Gamma-radiation-induced Apoptosis. Cell Death. Differ. 11, 853-861 (2004).
67. Tfelt-Hansen, J., Yano, S., Bandyopadhyay, S., Carroll, R., Brown, E. M., and Chattopadhyay, N. Expression of Pituitary Tumor Transforming Gene (PTTG) and its Binding Protein in Human Astrocytes and Astrocytoma Cells: Function and Regulation of PTTG in U87 Astrocytoma Cells. Endocrinology 145, 4222-4231 (2004).
68. Acker, T., Diez-Juan, A., Aragones, J., Tjwa, M., Brusselmans, K., Moons, L., Fukumura, D., Moreno-Murciano, M. P., Herbert, J. M., Burger, A., Riedel, J., Elvert, G., Flamme, I., Maxwell, P. H., Collen, D., Dewerchin, M., Jain, R. K., Plate, K. H., and Carmeliet, P. Genetic Evidence for a Tumor Suppressor Role of HIF-2alpha. Cancer Cell 8, 131-141 (2005).
69. Peng, Y., Woods, R. G., Beamish, H., Ye, R., Lees-Miller, S. P., Lavin, M. F., and Bedford, J. S. Deficiency in the Catalytic Subunit of DNA-dependent Protein Kinase Causes Down-regulation of ATM. Cancer Res. 65, 1670-1677 (2005).
70. Wischhusen, J., Friese, M. A., Mittelbronn, M., Meyermann, R., and Weller, M. HLA-E Protects Glioma Cells from NKG2D-mediated Immune Responses In Vitro: Implications for Immune Escape In Vivo. J. Neuropathol. Exp. Neurol. 64, 523-528 (2005).
71. Kawakami, K., Kioi, M., Liu, Q., Kawakami, M., and Puri, R. K. Evidence that IL-13Ralpha2 Chain in Human Glioma Cells is Responsible for the Antitumor Activity Mediated by Receptor-directed Cytotoxin Therapy. J. Immunother. 28, 193-202 (2005).
72. Friese, M. A., Wischhusen, J., Wick, W., Weiler, M., Eisele, G., Steinle, A., and Weller, M. RNA Interference Targeting Transforming Growth Factor-beta Enhances NKG2D-mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity In Vivo. Cancer Res. 64, 7596-7603 (2004).
73. Van Brocklyn, J. R., Jackson, C. A., Pearl, D. K., Kotur, M. S., Snyder, P. J., and Prior, T. W. Sphingosine Kinase-1 Expression Correlates with Poor Survival of Patients with Glioblastoma Multiforme: Roles of Sphingosine Kinase Isoforms in Growth of Glioblastoma Cell Lines. J. Neuropathol. Exp. Neurol. 64, 695-705 (2005).
74. Amos, S., Martin, P. M., Polar, G. A., Parsons, S. J., and Hussaini, I. M. Phorbol 12-myristate 13-acetate Induces Epidermal Growth Factor Receptor Transactivation Via Protein Kinase Cdelta/c-Src Pathways in Glioblastoma Cells. J. Biol. Chem. 280, 7729-7738 (2005).
75. Zhou, Y., Bian, X., Le, Y., Gong, W., Hu, J., Zhang, X., Wang, L., Iribarren, P., Salcedo, R., Howard, O. M., Farrar, W., and Wang, J. M. Formylpeptide Receptor FPR and the Rapid Growth of Malignant Human Gliomas. J. Natl. Cancer Inst. 97, 823-835 (2005).
76. Jiang, X. B., Zhao, H. Y. Zhou, F., Liu, R. E., Zhang, F. C., and Zhao, J. S. Vascular Endothelial Growth Factor shRNA Mediated by pEG-FP-H1 Vector Plasmid Effectively Inhibits Glioma Proliferation: An Experimental Study. Zhonghua Yi. Xue. Za Zhi. 85, 547-550 (2005).
77. Purow, B. W., Haque, R. M., Noel, M. W., Su, Q., Burdick, M. J., Lee, J., Sundaresan, T., Pastorino, S., Park, J. K., Mikolaenko, I., Maric, D., Eberhart, C. G., and Fine, H. A. Expression of Notch-1 and Its Ligands, Delta-like-1 and Jagged-1, is Critical for Glioma Cell Survival and Proliferation. Cancer Res. 65, 2353-2363 (2005).
78. Pardridge, W. M. Intravenous, Non-viral RNAi Gene Therapy of Brain Cancer. Expert. Opin. Biol. Ther. 4, 1103-1113 (2004).
79. Zhang, Y., Zhang, Y. F., Bryant, J., Charles, A., Boado, R. J., and Pardridge, W. M. Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain Cancer. Clin. Cancer Res. 10, 3667-3677 (2004).
80. Zhang, Y., Boado, R. J., and Pardridge, W. M. In Vivo Knockdown of Gene Expression in Brain Cancer with Intravenous RNAi in Adult Rats. J. Gene Med. 5, 1039-1045 (2003).
81. Boado, R. J., Li, J. Y. Chu, C., Ogoshi, F., Wise, P., and Pardridge, W. M. Site-directed Mutagenesis of Cysteine Residues of Large Neutral Amino Acid Transporter LAT1. Biochim. Biophys. Acta. 1715, 104-110 (2005).
82. Fan, Q. W. and Weiss, W. A. RNA Interference Against a Glioma-derived Allele of EGFR Induces Blockade at G2M. Oncogene 24, 829-837 (2005).
83. Di, C., Liao, S., Adamson, D. C., Parrett, T. J., Broderick, D. K., Shi, Q., Lengauer, C., Cummins, J. M., Velculescu, V. E., Fults, D. W., McLendon, R. E., Bigner, D. D., and Yan, H. Identification of OTX2 as a Medulloblastoma Oncogene Whose Product can be Targeted by All-trans Retinoic Acid. Cancer Res. 65, 919-924 (2005).
84. Lesniak, M. S. Novel Advances in Drug Delivery to Brain Cancer. Technol. Cancer Res. Treat. 4, 417-428 (2005).
85. Fountaine, T. M., Wood, M. J., and Wade-Martins, R. Delivering RNA Interference to the Mammalian Brain. Curr. Gene Ther. 5, 399-410 (2005).
86. Boado, R. J., Li, J. Y., Chu, C., Ogoshi, F., Wise, P., and Pardridge, W. M. Site-directed Mutagenesis of Cysteine Residues of Large Neutral Amino Acid Transporter LAT1. Biochim. Biophys. Acta. 1715, 104-110 (2005).
87. Giussani, C., Carrabba, G., Pluderi, M., Lucini, V., Pannacci, M., Caronzolo, D., Costa, F., Minotti, M., Tomei, G., Villani, R., Carroll, R. S., Bikfalvi, A., and Bello, L. Local Intracerebral Delivery of Endogenous Inhibitors by Osmotic Minipumps Effectively Suppresses Glioma Growth In Vivo. Cancer Res. 63, 2499-2505 (2003).